hrs4r
 I want to donate

JORDI MAYNERIS PERXACHS

Firma
JORDI MAYNERIS-PERXACHS
Position
Investigador/a Consolidat - R3
Established Researchers - R3

Projectes

Codi oficial: PI20/01090 Start date:01/01/2021 Data fi: 31/12/2024 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: SMARTAGE Start date:01/09/2020 Data fi: 31/08/2024 Investigador/a principal: JORDI MAYNERIS PERXACHS, JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION
Codi oficial: PMP21/00072 Start date:01/01/2022 Data fi: 31/12/2025 Investigador/a principal: JORDI MAYNERIS PERXACHS, JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: UKRI Cognitive Decline Start date:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: UK RESEARCH AND INNOVATION (UKRI)
Codi oficial: HR22-00737 Start date:01/10/2022 Data fi: 30/09/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUNDACIÓN BANCARIA LA CAIXA
Codi oficial: 2021 SGR 01263 Start date:01/01/2022 Data fi: 30/06/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA (AGAUR)
Codi oficial: 2023_FI_1 00515 Sara Pauli Start date:01/06/2023 Data fi: 31/05/2026 Investigador/a principal: JORDI MAYNERIS PERXACHS, SARA PAULÍ I PLA Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA (AGAUR)
Codi oficial: PI23/00575 Start date:01/01/2024 Data fi: 31/12/2026 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: INSTITUTO DE SALUD CARLOS III
Codi oficial: CNS2023-144218 Start date:01/04/2024 Data fi: 31/03/2026 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: MINISTERIO DE ECONOMIA Y COMPETITIVIDAD MINECO /
Codi oficial: 2023_IBEC_JMP Start date:01/03/2024 Data fi: 30/06/2025 Investigador/a principal: JORDI MAYNERIS PERXACHS Organisme finançador: FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Publicacions

Mayneris-Perxachs J, Castells-Nobau A, Fernández-Real JM

"Indole-gence"for the mind

CELL HOST & MICROBE, 2024, 32, 151-153 dx.doi.org/10.1016/j.chom.2024.01.006
Milbank E, Díaz-Trelles R, Dragano N, Latorre J, Mukthavaram R, Mayneris-Perxachs J, Ortega F, Federici M, Burcelin R, Karmali PP, Tachikawa K, Chivukula P, López M, Fernández-Real JM, Moreno-Navarrete JM

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

PHARMACOLOGICAL RESEARCH, 2023, 187, 106562-106562 dx.doi.org/10.1016/j.phrs.2022.106562
Paton B, Foguet-Romero E, Suarez M, Mayneris-Perxachs J, Boqué N, Caimari A, Canela N, Herrero P

Brain N-Glycosylation and Lipidomic Profile Changes Induced by a High-Fat Diet in Dyslipidemic Hamsters.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24032883
Sol J, Obis È, Mota-Martorell N, Pradas I, Galo-Licona JD, Martin-Garí M, Fernández-Bernal A, Ortega-Bravo M, Mayneris-Perxachs J, Borrás C, Viña J, de la Fuente M, Mate I, Biarnes C, Pedraza S, Vilanova JC, Brugada R, Ramos R, Serena J, Ramió-Torrentà L, Pineda V, Daunis-I-Estadella P, Thió-Henestrosa S, Barretina J, Garre-Olmo J, Portero-Otin M, Fernández-Real JM, Puig J, Jové M, Pamplona R

Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome.

Aging Cell, 2023, 22 dx.doi.org/10.1111/acel.13821
Mayneris-Perxachs J, Fernández-Real JM

Proline-related metabolites: Towards biological diagnosis of depression.

PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 77, 195-195 dx.doi.org/10.1111/pcn.13535
Arnoriaga-Rodríguez M, Leal Y, Mayneris-Perxachs J, Pérez-Brocal V, Moya A, Ricart W, Fernández-Balsells M, Fernández-Real JM

Gut microbiota composition and functionality are associated with REM sleep duration and continuous glucose levels.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108, 2931-2939 dx.doi.org/10.1210/clinem/dgad258
Swann JR, Diaz Heijtz R, Mayneris-Perxachs J, Arora A, Isaksson J, Bölte S, Tammimies K

Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins.

Neuropharmacology, 2023, 234, 109562-109562 dx.doi.org/10.1016/j.neuropharm.2023.109562
Sojo L, Santos-González E, Riera L, Aguilera A, Barahona R, Pellicer P, Buxó M, Mayneris-Perxachs J, Fernandez-Balsells M, Fernández-Real JM

Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes.

Antioxidants, 2023, 12 dx.doi.org/10.3390/antiox12051132
Oliveras-Cañellas N, Castells-Nobau A, de la Vega-Correa L, Latorre-Luque J, Motger-Albertí A, Arnoriaga-Rodriguez M, Garre-Olmo J, Zapata-Tona C, Coll-Martínez C, Ramió-Torrentà L, Moreno-Navarrete JM, Puig J, Villarroya F, Ramos R, Casadó-Anguera V, Martín-García E, Maldonado R, Mayneris-Perxachs J, Fernández-Real JM

Adipose tissue coregulates cognitive function.

Science Advances, 2023, 9 dx.doi.org/10.1126/sciadv.adg4017
Schoeler M, Ellero-Simatos S, Birkner T, Mayneris-Perxachs J, Olsson L, Brolin H, Loeber U, Kraft JD, Polizzi A, Martí-Navas M, Puig J, Moschetta A, Montagner A, Gourdy P, Heymes C, Guillou H, Tremaroli V, Fernández-Real JM, Forslund SK, Burcelin R, Caesar R

The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis.

NATURE COMMUNICATIONS, 2023, 14, 5329-5329 dx.doi.org/10.1038/s41467-023-41074-3

Formulari de contacte

About IDIBGI!

menu